Status:
COMPLETED
Neuromuscular Blockade: Outcome and Recovery for Laparoscopic Bariatric Surgery
Lead Sponsor:
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Bariatric Surgery Candidate
Eligibility:
All Genders
18+ years
Brief Summary
The aim of the current observational study is to better assess the relationships between neuromuscular blockade and multiple surgical outcomes in patients undergoing elective laparoscopic bariatric su...
Detailed Description
Performing bariatric surgery as a short-stay procedure is an ongoing trend in many centers around the world. For morbidly obese (MO) patients, the anesthetic approach is based on choosing drugs that h...
Eligibility Criteria
Inclusion
- MO patients \[body mass index (BMI)≤ 55kg/m2\] scheduled for elective laparoscopic sleeve gastrectomy under general anesthesia.
Exclusion
- a physical status \>3 (ASA),
- a difficult tracheal intubation,
- a known or suspected disorder affecting NMB,
- a renal, pulmonary, cardiac, and/or hepatic dysfunction,
- malignant hyperthermia,
- pregnancy, breastfeeding,
- allergy or contraindication to narcotics, rocuronium, neostigmine, or other medications used during anesthesia
- patients with sleep apnea syndrome will also be excluded.
Key Trial Info
Start Date :
September 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT02300168
Start Date
September 1 2014
End Date
December 1 2014
Last Update
August 19 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.